Merck (MRK) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $18.2 billion.
- Merck's Cash & Current Investments rose 2481.33% to $18.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 billion, marking a year-over-year increase of 2481.33%. This contributed to the annual value of $13.7 billion for FY2024, which is 9299.31% up from last year.
- As of Q3 2025, Merck's Cash & Current Investments stood at $18.2 billion, which was up 2481.33% from $8.6 billion recorded in Q2 2025.
- Merck's 5-year Cash & Current Investments high stood at $18.2 billion for Q3 2025, and its period low was $5.6 billion during Q1 2024.
- Moreover, its 5-year median value for Cash & Current Investments was $9.2 billion (2025), whereas its average is $10.1 billion.
- Per our database at Business Quant, Merck's Cash & Current Investments plummeted by 4623.26% in 2023 and then soared by 9299.31% in 2024.
- Over the past 5 years, Merck's Cash & Current Investments (Quarter) stood at $8.1 billion in 2021, then soared by 62.94% to $13.2 billion in 2022, then crashed by 46.23% to $7.1 billion in 2023, then soared by 92.99% to $13.7 billion in 2024, then soared by 33.06% to $18.2 billion in 2025.
- Its Cash & Current Investments stands at $18.2 billion for Q3 2025, versus $8.6 billion for Q2 2025 and $9.2 billion for Q1 2025.